Literature DB >> 34772342

Does the combination of resistance training and a nutritional intervention have a synergic effect on muscle mass, strength, and physical function in older adults? A systematic review and meta-analysis.

MoonKi Choi1, Hayeon Kim2, Juyeon Bae3.   

Abstract

BACKGROUND: Health-promoting interventions are important for preventing frailty and sarcopenia in older adults. However, there is limited evidence that nutritional interventions yield additional effects when combined with resistance training. This systematic review and meta-analysis aimed to compare the effectiveness of nutritional interventions with resistance training and that of resistance training alone.
METHODS: Randomized controlled trials published in peer-reviewed journals prior to July 2020 were retrieved from databases and other sources. The articles were screened according to the inclusion and exclusion criteria. The methodological quality of the included studies was assessed using Cochrane's risk of bias tool 2. A meta-analysis was performed using the RevMan 5.4 program and STATA 16 program.
RESULTS: A total of 22 studies were included in the meta-analysis. The results of the meta-analysis showed no significant differences between groups in muscle mass, muscle strength, or physical functional performance. In the subgroup analysis regarding the types of nutritional interventions, creatine showed significant effects on lean body mass (n = 4, MD 2.61, 95% CI 0.51 to 4.72). Regarding the other subgroup analyses, there were no significant differences in appendicular skeletal muscle mass (p = .43), hand grip strength (p = .73), knee extension strength (p = .09), chair stand test results (p = .31), or timed up-and-go test results (p = .31). In the meta-regression, moderators such as the mean age of subjects and duration of interventions were not associated with outcome variables.
CONCLUSIONS: This meta-analysis showed that nutritional interventions with resistance training have no additional effect on body composition, muscle strength, or physical function. Only creatine showed synergistic effects with resistance training on muscle mass. TRIAL REGISTRATION: CRD42021224843 .
© 2021. The Author(s).

Entities:  

Keywords:  Exercise; Frailty; Nutrition; Older adults; Resistance training; Sarcopenia

Mesh:

Year:  2021        PMID: 34772342      PMCID: PMC8588667          DOI: 10.1186/s12877-021-02491-5

Source DB:  PubMed          Journal:  BMC Geriatr        ISSN: 1471-2318            Impact factor:   3.921


Background

Age-related conditions and chronic diseases increase the risk of disability and dependence, which are considered nearly irreversible conditions. Increasingly more older adults are becoming interested in ‘active aging’, which refers to the process of optimizing opportunities for health, participation, and security later in life [1]. A growing research topic is the identification of factors that increase the risk of negative events and the development of preventive interventions against disability. In this context, frailty and sarcopenia have increasingly emerged as research interests. Although there is still no consensus on the definition and measurement of frailty for diagnosis, frailty is defined as a geriatric condition characterized by a cumulative decline in functioning and accompanied by increased vulnerability to stressors and dependency [2]. In 2001, Fried et al. [3] suggested the following criteria of frailty as a physical phenotype, focusing on physiological components: unintentional weight loss, exhaustion, decreased physical activity, a slow walking speed, and muscle weakness. Rockwood and Mitnitski [4] introduced a frailty index based on the accumulation of age-related deficits. A recent consensus more broadly suggested that frailty is a multidimensional syndrome including sensory limitations, cognitive decline, mood-related conditions, changes in the social environment, comorbidities and disability in addition to physical impairment [5]. The specific pathological pathway of frailty remains unclear, but frailty has a biological component resulting from inflammation and cumulative cellular damage over one’s lifetime. Although it occurs independently of chronological age, frailty is more prevalent in people of an older age; females; those who are living alone; those with low educational and socioeconomic statuses, multimorbidity, malnourishment, depression, polypharmacy, cognitive impairment, and a low physical activity level; and those who smoke and drink alcohol regularly [6-8]. Sarcopenia is considered a muscle disorder associated with poor muscle function; low muscle mass is considered a principal determinant. Although sarcopenia occurs in people who are not elderly, muscle mass decreases with age [9]. There are several operational definitions of sarcopenia; for example, the European working group on sarcopenia in older people defines sarcopenia as a combination of low muscle mass and strength and/or poor physical function [10]. Inconsistency in the definition leads to a wide range of prevalence rates, ranging from 9.9 to 40.4% [11]. Although the concepts of both frailty and sarcopenia are still being developed, the physical phenotypes of frailty, including low grip strength and slow gait speed described by Fried et al. [3], overlap substantially with those of sarcopenia [12]. In addition, as the etiology of frailty, such as inflammation, cellular damage, and protein degradation, is also related to that of sarcopenia, sarcopenia is an essential component of physical frailty. Frailty with sarcopenia can result in falls and fractures, a loss of independence, disability, morbidities, social isolation, institutionalization, and hospitalization [6, 13, 14], which lead to increases in healthcare costs and social burden [15]. Physical frailty and sarcopenia are transitional processes that increase individuals’ vulnerability to reduced functional capacity and adverse health outcomes. Issues related to healthcare and support for frail and sarcopenic older adults are expected to increase with population aging [16]. Health-promoting behaviors are important to prevent disability and dependence and to reduce the need for care [17]. Physical inactivity and malnutrition are common conditions in older adults and are major modifiable risk factors for frailty and sarcopenia [18, 19]. An increasing amount of research has suggested that physical inactivity can lead to the loss of muscle mass, decreases in muscle strength and poor physical performance. Several evidence-based systematic reviews and meta-analyses of RCTs have shown that exercise affects muscle mass, strength, and physical performance [17, 20]. For optimal effects, multimodal exercise combined with moderate- to high-intensity progressive resistance training and functional balance and mobility training at least twice a week for 30–45 min per session is recommended [19, 21]. Several nutrients, such as protein and vitamins D and E, have been known to affect anabolic stimuli, lead to the synthesis of muscle proteins, and protect against oxidative damage and the loss of muscle mass [22]. Although nutrition plays a key role in the pathogenesis of physical frailty and sarcopenia, the effects of nutritional interventions on muscle mass, strength and physical function are unclear. A systematic review showed that dietary supplementation, when combined with exercise training, has been shown to yield additional effects on muscle mass, strength and physical performance in some studies, but the existing evidence was inconsistent [23]. A more recent systematic review and meta-analysis by Hita-Contreras et al. showed that nutritional interventions do not provide additional or synergistic benefits when combined with resistance exercise in terms of muscle strength and mobility improvements among older adults with sarcopenic obesity [20]. There is evidence suggesting that there is an interaction effect between exercise and various nutritional factors, particularly protein and some multinutrient supplements, that can slow age-related decline and preserve muscle function in older adults. However, whether this has a meaningful preventive effect on frailty and sarcopenia remains unclear. Some previous reviews did not provide a quantitative synthesis, combined community-dwelling and institutionalized populations, or included and analyzed diverse types of interventions together [17, 23, 24], making it difficult to interpret the results. Thus, we focused on the primary prevention and synergistic effects of nutritional interventions, that is, the changes in muscle function after resistance training and nutritional interventions, in healthy community-dwelling older adults. The aim of this systematic review and meta-analysis was to compare the combination of resistance training and nutritional interventions with resistance training alone. A preferred reporting items for systematic reviews and meta-Analyses (PRISMA) checklist is presented in Additional file 1.

Methods

Search strategy

Electronic databases and the reference lists of related studies were searched by two investigators. First, for the electronic search, MEDLINE (PubMed), Cochrane CENTRAL, and Embase were searched for articles published prior to July 2020 by entering the following combinations of keywords: (“nutrition” OR “food” OR “diet”) OR (“exercise” OR “resistance training”) AND “aged” AND (“muscle mass” or “skeletal muscle” OR “muscle strength” OR “physical performance” OR “physical functional performance” OR “walking speed” OR “gait speed”). Second, the reference lists of related studies were searched to identify additional articles. The searches were limited to articles published in the English language, studies involving humans, and RCTs. Only peer-reviewed articles were included, and gray literature such as dissertations, proceedings, and government reports was excluded.

Study selection

The inclusion criteria for this systematic review were as follows: (a) studies including community-dwelling healthy older adults aged 60 years or above; (b) those including experimental groups that underwent resistance training and nutritional interventions; (c) those including comparison groups that underwent resistance training alone with or without a nutritional placebo supplement; (d) studies that reported the outcome measures of muscle mass, muscle strength, and physical functional performance; and (e) randomized controlled parallel-group trials with at least one arm. We set the age of 60 years or above, the age at which the activity level can decrease after retirement [25] and the loss of muscle strength accelerates [26]. We included only studies in healthy subjects to reduce the level of heterogeneity between studies. We accepted the various authors’ own definitions of ‘healthy’. The experimental interventions included any form of resistance training and nutritional (dietary) interventions that involved repeated practice during standardized programs for the purpose of enhancing muscle mass, muscle strength, and physical function. Nutritional interventions were defined as those that provided at least one nutrient through nutritional supplementation or whole food to obtain biologically beneficial effects. There was no minimum duration of follow-up. However, all included trials had to report outcomes at a minimum of one time point after the completion of the intervention. Articles were excluded if (a) the participants had malignant tumors, severe chronic diseases, or levels of frailty and sarcopenia that limited their physical activity, diet, and level of independence in daily life; (b) the study was conducted in an animal model; (c) the experimental intervention was combined with any other form of interventions, such as medication and hormone therapy; (d) the nutritional intervention was designed for calorie intake reduction and weight loss; (e) the study evaluated the effectiveness of experimental interventions by only examining inflammatory factors or biological markers related to muscle synthesis; or (f) the study had a non-RCT design, such as case reports or cohort studies, without a comparison group. Studies were selected based on the inclusion and exclusion criteria by two independent researchers; these researchers screened the studies according to the titles and abstracts of all studies and then reviewed the full texts of the remaining studies. Disagreements between researchers were resolved by discussion.

Data extraction

Two independent researchers extracted key data from the included articles in a standardized Excel sheet, and the results were cross checked. For each article, data about (a) the article, including the authors, year of publication, and country; (b) characteristics of the study population, including the number of participants, mean age, sex, health status, and attrition rate; (c) characteristics of the experimental intervention, including the contents of resistance training, contents of nutritional intervention, delivery mode, amount, frequency and duration of intervention, and treatment for comparison group; and (d) outcome evaluation, including the follow-up period and the method of measurement. As the aim of the study was to compare the effects of the combination of resistance training and nutritional interventions with those of resistance training alone on muscle mass, strength, and physical performance, when more than two groups were present, only the data we intended to compare were recorded.

Assessment of risk of Bias

Methodological quality was assessed using Cochrane’s risk of bias 2 (RoB2) tool by two independent researchers. The RoB2 tool consists of five domains: the randomization process, deviation from intended intervention, missing outcome data, measurement of outcome, and selection of the reported result. The risk of bias for each domain is evaluated as “low risk”, “some concerns”, or “high risk” by an algorithm with several signaling questions. Overall, “low risk of bias” was recorded when the study was judged to have a low risk of bias for all domains, “some concerns” was recorded when the study was judged to have some concerns in at least one domain, and “high risk of bias” was recorded when the study was judged to have a high risk of bias in at least one domain. This process was carried out by two independent researchers, and inconsistencies were resolved through discussion.

Data synthesis and statistical analysis

The effect sizes of the combination of resistance training and a nutritional intervention were calculated using the mean difference (MD) or standardized MD (SMD) for continuous outcome data for muscle mass, muscle strength, and physical functional performance. When a study provided data on more than one outcome for the same construct (ex: timed up-and-go and 4-m walk tests for physical functional performance), valid, reliable and commonly used measures for frailty and sarcopenia were selected by reviewing the associated literature and considering the frequencies of their use in the included studies. As a result, lean body mass and appendicular skeletal muscle mass were selected for muscle mass, hand grip strength and knee extension strength for muscle strength, and the chair stand tests and timed up-and-go tests for physical functional performance. Fat-free mass was included in the analysis when lean body mass was not available. In addition, if a study used different lengths of intervention and follow-up periods, we used the outcome values at the postintervention endpoint. When only the mean change scores and standard deviation (SD) of each group were available, they were used instead of the postintervention endpoint mean and SD for the mean difference. SMDs were used for studies using different units (scale) of the same measure (ex: kg and Nm for strength). If there were more than two groups that could be considered experimental groups in the study, the groups were combined to create a single pairwise comparison in the meta-analysis to avoid unit-of-analysis error from multiple comparisons as recommended [27]. Studies for which we could not identify the outcome data necessary for quantitative synthesis after contacting the authors were excluded from this meta-analysis. Meta-analysis was conducted using Review Manager (RevMan) 5.4. Individual MDs and SMDs were pooled using random effects models and the inverse variance method. The statistical significance of each effect size and overall effect size were checked using 95% confidence intervals. The chi-squared test and Higgin’s I2 test were used to examine between-trial heterogeneity. When the p value for the chi-squared test was less than 0.1 and I2 was greater than 50%, substantial heterogeneity was considered to be present. Subgroup analysis was conducted by nutritional intervention type. All subgroup differences were tested regarding the significance of the effect sizes and heterogeneity. Meta-regression was conducted to identify the potential effect moderator using the STATA 16 program. p values from random effect meta-regression were calculated using restricted maximum likelihood for continuous moderators.

Certainty of evidence

The Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool approach was used to assess the quality of evidence. It compared the resistance training combined diet compared to resistance training only for muscle function. The GRADE tool comprised of risk of bias, inconsistency, indirectness, imprecision, publication bias. The grading was estimated as high, moderate, low and very low certainty of quality.

Results

Search results

Figure 1 demonstrates the study selection process. After duplicates were removed, 3641 articles remained. After 3549 articles were excluded through title and abstract review, the full texts of 92 articles were reviewed. Sixty-seven articles were additionally excluded, and consequently, 25 articles were included in this systematic review. In some papers, the necessary values for meta-analysis could not be identified, so 22 articles were included in the quantitative synthesis.
Fig. 1

Flow diagram of the study selection process

Flow diagram of the study selection process

Description of included studies

Table 1 shows the characteristics of the included studies. Six RCTs were conducted in Canada, six in Japan, four in Brazil, two in the Netherlands, two in the USA and one each in France, Iceland, Norway, Sweden, and the UK. The studies were published between 1998 and 2020. The sample sizes ranged from 14 to 161. Six studies were conducted in males only, five studies were conducted in females only, and 14 studies were conducted in both males and females. There were 12 studies with a mean age of participants of less than 70 years and 13 studies with a mean age of more than 70 years.
Table 1

Summary of included study characteristics

First author (year), study locationSample characteristics: n, mean age ± SD, sex (female ratio)Intervention groupControl groupaFollow-up period (weeks)bBody composition assessment methodMuscle strength assessment methodPhysical performance assessment method
ExerciseNutrition
Aguiar (2013) [28], Brazil

Ic: 9, 64 ± 4, female

Cd: 9, 65 ± 6, female

Resistance training using machines, 60 min sessions, 3 times a week, for 24 weeks5 g Creatine monohydrate, once a day, for 12 weeksPlacebo: maltodextrin24

Body mass

Fat free mass

Muscle mass

Bench press

Biceps curl

Knee extension

Chair stand
Aoki (2018) [29], Japan

I: 43, 68.8 ± 5.3, mixed (74.4%)

C: 45, 71.2 ± 6.8, mixed (75.6%)

Lower body resistance training, daily25mcg vitamin D3 (1000 IUe), divided into 3 times, dailyUsual diet24

BMIf

Lower limb muscle mass

Hip flexion

Knee extension

Chair stand

Single leg stance

Two step test

Functional reach test

Arnarson (2013) [30], Iceland

I: 83, 73.3 ± 6, mixed (unknown)

C: 78, 74.6 ± 5.8, mixed (unknown)

Resistance training using machines, 3 times a week20 g of whey protein 3 times a weekPlacebo: 250 ml isocaloric carbohydrate drink12

ASMMg

Lean body mass

Grip strength

Knee extension

TUGh

6-min walk

Bermon (1998) [31], France

I: 8, 71.0 ± 5.4, mixed (50%)

C: 8, 69.3 ± 1.1, mixed (50%)

Resistance training using machines, 3 times a week, for 7 weeks

First 5 days: 5 g creatine monohydrate and 2 g glucose, 4 times a day

Following 47 days: 3 g creatine monohydrate and 2 g glucose once a day

Placebo:

First 5 days:7 g glucose 4 times a day

Following 47 days: 5 g glucose once a day

8

Body mass

BMI

Lower limb muscle volume

Leg press

Chest press

Knee extension

Bjørnsen (2016) [32], Norway

I: 17, 69 ± 7, male

C: 17, 67 ± 5, male

Free weight exercises, 3 times a week500 mg vitamin C and 117.5 mg vitamin E, twice a dayPlacebo: cellulose and dicalsium phosphate12

Lean body mass

Muscle thickness

Biceps curl

Knee extension

Leg press

Bobeuf (2011) [33], Canada

I: 14, 64.3 ± 3.8, mixed (50%)

C: 17, 67 ± 3.7, mixed (52.9%)

Resistance training, 60 min sessions, 3 times a week1000 mg vitamin C ascorbate and vitamin E, once a dayPlacebo: 100 mg lactose24

ASMM

Muscle mass

Brose (2003) [34], Canada

I: 14, 69.6 ± 5.4, mixed (42.8%)

C: 14, 69.1 ± 4.8, mixed (50%)

Resistance training using machines, 3 times a week5 g creatine and 2 g dextrose, once a day

Placebo:

7 g dextrose

14Fat free mass

Grip strength

Knee extension

Leg press

Chrusch (2001) [35], Canada

I:16, 70.4 ± 6.4, male

C:14, 71.1 ± 6.7, male

Resistance training using machines, 3 times a weekCreatine supplement: 0.3 g/kg/day for the first 5 days (loading phase) and 0.07 g/kg/day thereafter, once a day, for 11 weeksPlacebo: sucrose-flour mixture12Lean body mass

Bench press

Knee extension

Leg press

Cornish (2018) [36], Canada

I:11, 71.4 ± 6.2, male

C:12, 70.9 ± 5, male

Resistance training, 60 min sessions, 3 times a week

3.0 g omega-3 fatty acid

combined 1.98 g EPAi and 0.99 g DHAj, once a day

Placebo:

3.0 g omega 3–6-9 blend

12

Body mass

Lean body mass

Chest press

Leg press

TUG

6-min walk

Da Boit (2017) [37], UK

I: 27, 70.1 ± 4, mixed (48.1%)

C: 23, 70.9 ± 4.2, mixed (43.4%)

Lower body resistance training, twice a week3.0 g omega–3 fatty acids containing 2.1 g EPA and 0.6 g DHA, once a day

Placebo:

3.0 g safflower oil

18Muscle anatomic cross-sectional areaKnee extension

Chair stand

SPPBk

4 m walk

Edholom (2017) [38], Sweden

I: 20, 67.2 ± 1.3, female

C: 17, 67.9 ± 2.1, female

Resistance training, 60 min sessions, twice a week

Healthy diet:

following a dietary consultation and a diet plan with the current dietary guidelines in Europe and US

Usual diet24Lean body mass

Knee extension

Leg press

Chair stand

Single leg stance

Squat jump

TUG

Holwerda (2018) [39], Netherlands

I: 21, 69 ± 4.6, male

C: 20, 71 ± 4.5, male

Resistance exercise training,

3 times a week

21 g leucine-enriched whey protein (3 g total leucine), once a dayPlacebo12

ASMM

BMI

Body mass

Lean body mass

Knee extension

Leg press

Chair stand

SPPB

4 m walk

Kawada (2013) [40], Japan

Ia: 10, 65 ± 1, mixed (50%)

Ib: 11, 67 ± 3, mixed (72.3%)

C: 8, 70 ± 1, mixed (50%)

Low-intensity resistance training, twice a week

Ia: 3.0 g essential amino acid supplements with milk, twice a day

Ib: 6.0 g essential amino acid supplements with milk, twice a day

Placebo:

3 g dextrin-contained powder with milk, once a day

24Cross sectional area of Psoas major muscle

Gait speed

Obstacle course walk

6-min walk

Leenders (2013) [41], Netherlands

I: 27,70.9 ± 5.4, mixed (44.4%)

C: 26, 69.5 ± 3.6, mixed (46.2%)

Resistance training, 3 times a week15 g milk protein, once a day

Placebo:

7.13 g lactose and 0.42 g calcium only

24

BMI

Lean body mass

Lower limb lean mass

Grip strength

Leg press

Chair stand
Mori (2018) [42], Japan

I: 25, 70.6 ± 4.2, female

C: 25, 70.6 ± 4.2, female

Resistance training, twice a week25 g leucine enriched whey protein, once a dayUsual diet24

BMI

Lower limb lean mass SMIl

Upper limb lean mass

Grip strength

Knee extension

Gait speed
Nabuco (2018) [43], Brazil

Ia: 23, 66.2 ± 9.4, female

Ib: 24, 67.5 ± 5.2, female

C: 23, 66.5 ± 7.2, female

Resistance training, 3 times a week

Ia: 27.1 g whey protein after resistance training, 3 times a week

Ib: 27.1 g whey protein before resistance training, 3 times a week

Placebo:

maltodextrin drink

12

Lower limb lean mass

Skeletal muscle mass

Upper limb lean mass

Biceps curl

Chest press

Knee extension

Chair stand

Gait speed

Nagai (2019) [44], Japan

I: 17, 72.7 ± 1.4, mixed (64.7%)

C: 19, 73.5 ± 2.3, mixed (68.4%)

Latex band training, squat, and tai chi, 90 min sessions, once a week60 mg maslinic acid, once a day

Placebo:

jelly without maslinic acid

12

BMI

Body mass

Fat free mass

Skeletal muscle mass

Segmental muscle mass

Grip strength

Chair stand

Gait speed

Nakayama (2020) [45], Japan

I: 61, 71.4 ± 6.2, mixed (74%)

C: 61, 70.4 ± 5.5, mixed (77%)

Body weight exercises and 5 medicine ball exercises, daily

Low-dose milk protein:

10.1 g protein, once a day

Placebo:

Isocaloric carbohydrate

24

Body mass

Lean body mass

Grip strength

Knee extension

Knee flexion

Push up

Chair stand

Gait speed

TUG

Nilsson (2020) [46], Canada

I: 16, 77.4 ± 11.2, male

C: 16, 74.4 ± 5.2, male

Home based resistance training with elastic bands, 3 times a weekMulti nutrients: 24 g whey protein, 16 g micellar casein contained 416 mg calcium, 3 g creatine, vitamin D 1000 IU, and omega-3 fish-oil containing 1.51 g EPA and 0.95 g DHA, once a dayPlacebo: collagen and sunflower oil12

ASMM

Body mass BMI

Lean body mass

Grip strength Knee extension

Leg press

Chair stand

SPPB

Stair climb

TUG

4 m walk

Pinto (2016) [47], Brazil

I: 13, 67.4 ± 4.7, mixed (unknown)

C: 14, 67.1 ± 6.3, mixed (unknown)

Resistance training, 3 times a week5 g Creatine monohydrate, once a dayPlacebo: 5 g maltodextrin12

Body mass

Lean body mass

SMI

Bench press

Leg press

Seino (2018) [48], Japan

I: 40, 73.4 ± 4.3, mixed (85%)

C: 40, 73.7 ± 4.3, mixed (82.5%)

Weight-bearing exercise and exercises using a resistance band and Pilates ball, 60 min sessions, twice a weekFortified milk containing 10.5 g total milk protein, 3.9 g fat, 9.3 g carbohydrate, and 337 mg calcium at lunch and micronutrient beverage at breakfast, dailyUsual diet12

Body mass

Lean body mass

Lower limb lean mass SMI

Grip strength Knee extension

Chair stand

Gait speed

One leg standing with eyes open

TUG

Stout (2013) [49], USA

I: 24, 73 ± 4.9, mixed (54.2%)

C: 24, 73 ± 4.9, mixed (54.2%)

Resistance exercise, 3 times a week for 21 weeks1.5 g calcium and 4 g carbohydrate, twice a dayPlacebo: 200 mg calcium and 4 g carbohydrate24

Lean body mass

Lower limb lean mass Upper limb lean mass

Grip strengthChair stand
Sugihara Junior (2018) [50],  Brazil

I: 15, 67.4 ± 4.1, female

C: 16, 67.8 ± 4.1, female

Resistance training using a combination of free weights and machines, 45 ~ 50 min sessions, 3 times a week35 g whey protein, immediately after each resistance training

Placebo:

35 g maltodextrin

12

Body mass

BMI

Lower limb lean mass SMI

Upper limb lean mass

Biceps curl Chest press

Knee extension

Tarnopolsky (2007) [51], Canada

I: 21,70.7 ± 4.5, mixed (47.6%)

C: 18, 71.1 ± 5.5, mixed (55.6%)

Resistance exercise using machines, twice a week5 g creatine monohydrate and 6 g conjugated linoleic acid, once a dayPlacebo: dextrose and safflower oil24

Body mass BMI

Fat free mass

Biceps curl Chest press

Knee extension

Leg press

Chair stand

Gait speed

Stair climb

Standing balance

Villanueva (2014) [52], USA

I: 7, 68.7 ± 6.8, male

C: 7, 68.7 ± 6.6, male

Progressive overload, total body periodized resistance program, 3 times a week

First 5 days: 0.1 g/kg body weight of creatine 3 times a day and 35 g whey protein once a day

Following days: 0.07 g/kg body weight of creatine and 35 g whey protein, once a day

Usual diet12Lean body mass

Bench press

Leg press

Stair climb

400 m walk

aThe resistance exercise of the control group applied in the same manner as in the experimental group

b The duration of intervention in most studies were the same as the follow-up period

c I, intervention group d C, control group e IU, international unit f BMI, body mass index g ASMM, appendicular skeletal muscle mass, h TUG, timed up and go i EPA, eicosapentaenoic acid j DHA, docosahexaenoic acid k SPPB, short physical performance battery l SMI, skeletal muscle mass index

Summary of included study characteristics Ic: 9, 64 ± 4, female Cd: 9, 65 ± 6, female Body mass Fat free mass Muscle mass Bench press Biceps curl Knee extension I: 43, 68.8 ± 5.3, mixed (74.4%) C: 45, 71.2 ± 6.8, mixed (75.6%) BMIf Lower limb muscle mass Hip flexion Knee extension Chair stand Single leg stance Two step test Functional reach test I: 83, 73.3 ± 6, mixed (unknown) C: 78, 74.6 ± 5.8, mixed (unknown) ASMMg Lean body mass Grip strength Knee extension TUGh 6-min walk I: 8, 71.0 ± 5.4, mixed (50%) C: 8, 69.3 ± 1.1, mixed (50%) First 5 days: 5 g creatine monohydrate and 2 g glucose, 4 times a day Following 47 days: 3 g creatine monohydrate and 2 g glucose once a day Placebo: First 5 days:7 g glucose 4 times a day Following 47 days: 5 g glucose once a day Body mass BMI Lower limb muscle volume Leg press Chest press Knee extension I: 17, 69 ± 7, male C: 17, 67 ± 5, male Lean body mass Muscle thickness Biceps curl Knee extension Leg press I: 14, 64.3 ± 3.8, mixed (50%) C: 17, 67 ± 3.7, mixed (52.9%) ASMM Muscle mass I: 14, 69.6 ± 5.4, mixed (42.8%) C: 14, 69.1 ± 4.8, mixed (50%) Placebo: 7 g dextrose Grip strength Knee extension Leg press I:16, 70.4 ± 6.4, male C:14, 71.1 ± 6.7, male Bench press Knee extension Leg press I:11, 71.4 ± 6.2, male C:12, 70.9 ± 5, male 3.0 g omega-3 fatty acid combined 1.98 g EPAi and 0.99 g DHAj, once a day Placebo: 3.0 g omega 3–6-9 blend Body mass Lean body mass Chest press Leg press TUG 6-min walk I: 27, 70.1 ± 4, mixed (48.1%) C: 23, 70.9 ± 4.2, mixed (43.4%) Placebo: 3.0 g safflower oil Chair stand SPPBk 4 m walk I: 20, 67.2 ± 1.3, female C: 17, 67.9 ± 2.1, female Healthy diet: following a dietary consultation and a diet plan with the current dietary guidelines in Europe and US Knee extension Leg press Chair stand Single leg stance Squat jump TUG I: 21, 69 ± 4.6, male C: 20, 71 ± 4.5, male Resistance exercise training, 3 times a week ASMM BMI Body mass Lean body mass Knee extension Leg press Chair stand SPPB 4 m walk Ia: 10, 65 ± 1, mixed (50%) Ib: 11, 67 ± 3, mixed (72.3%) C: 8, 70 ± 1, mixed (50%) Ia: 3.0 g essential amino acid supplements with milk, twice a day Ib: 6.0 g essential amino acid supplements with milk, twice a day Placebo: 3 g dextrin-contained powder with milk, once a day Gait speed Obstacle course walk 6-min walk I: 27,70.9 ± 5.4, mixed (44.4%) C: 26, 69.5 ± 3.6, mixed (46.2%) Placebo: 7.13 g lactose and 0.42 g calcium only BMI Lean body mass Lower limb lean mass Grip strength Leg press I: 25, 70.6 ± 4.2, female C: 25, 70.6 ± 4.2, female BMI Lower limb lean mass SMIl Upper limb lean mass Grip strength Knee extension Ia: 23, 66.2 ± 9.4, female Ib: 24, 67.5 ± 5.2, female C: 23, 66.5 ± 7.2, female Ia: 27.1 g whey protein after resistance training, 3 times a week Ib: 27.1 g whey protein before resistance training, 3 times a week Placebo: maltodextrin drink Lower limb lean mass Skeletal muscle mass Upper limb lean mass Biceps curl Chest press Knee extension Chair stand Gait speed I: 17, 72.7 ± 1.4, mixed (64.7%) C: 19, 73.5 ± 2.3, mixed (68.4%) Placebo: jelly without maslinic acid BMI Body mass Fat free mass Skeletal muscle mass Segmental muscle mass Chair stand Gait speed I: 61, 71.4 ± 6.2, mixed (74%) C: 61, 70.4 ± 5.5, mixed (77%) Low-dose milk protein: 10.1 g protein, once a day Placebo: Isocaloric carbohydrate Body mass Lean body mass Grip strength Knee extension Knee flexion Push up Chair stand Gait speed TUG I: 16, 77.4 ± 11.2, male C: 16, 74.4 ± 5.2, male ASMM Body mass BMI Lean body mass Grip strength Knee extension Leg press Chair stand SPPB Stair climb TUG 4 m walk I: 13, 67.4 ± 4.7, mixed (unknown) C: 14, 67.1 ± 6.3, mixed (unknown) Body mass Lean body mass SMI Bench press Leg press I: 40, 73.4 ± 4.3, mixed (85%) C: 40, 73.7 ± 4.3, mixed (82.5%) Body mass Lean body mass Lower limb lean mass SMI Chair stand Gait speed One leg standing with eyes open TUG I: 24, 73 ± 4.9, mixed (54.2%) C: 24, 73 ± 4.9, mixed (54.2%) Lean body mass Lower limb lean mass Upper limb lean mass I: 15, 67.4 ± 4.1, female C: 16, 67.8 ± 4.1, female Placebo: 35 g maltodextrin Body mass BMI Lower limb lean mass SMI Upper limb lean mass Biceps curl Chest press Knee extension I: 21,70.7 ± 4.5, mixed (47.6%) C: 18, 71.1 ± 5.5, mixed (55.6%) Body mass BMI Fat free mass Biceps curl Chest press Knee extension Leg press Chair stand Gait speed Stair climb Standing balance I: 7, 68.7 ± 6.8, male C: 7, 68.7 ± 6.6, male First 5 days: 0.1 g/kg body weight of creatine 3 times a day and 35 g whey protein once a day Following days: 0.07 g/kg body weight of creatine and 35 g whey protein, once a day Bench press Leg press Stair climb 400 m walk aThe resistance exercise of the control group applied in the same manner as in the experimental group b The duration of intervention in most studies were the same as the follow-up period c I, intervention group d C, control group e IU, international unit f BMI, body mass index g ASMM, appendicular skeletal muscle mass, h TUG, timed up and go i EPA, eicosapentaenoic acid j DHA, docosahexaenoic acid k SPPB, short physical performance battery l SMI, skeletal muscle mass index All of the studies administered supervised exercise programs except one study [46] which included home-based resistance training with consistent encouragement. In almost all the studies, the exercise programs were performed twice (6 studies) or three times (16 studies) a week on nonconsecutive days; the exercise programs were performed daily in two studies and once a week in one study. The RCTs provided protein (eight studies), creatine (five studies), long chain n-3 polyunsaturated fatty acids (PUFA omega-3) (two studies), calcium (one study), maslinic acid (one study), vitamins C and E (two studies), creatine and linoleic acid (one study), creatine and protein (one study), vitamin D (one study), and multinutrients containing more than three nutrients (three studies). Most studies provided nutritional supplements in pill, capsule, powder or drink forms, and a study provided a personalized and nutritionally balanced diet [38]. Most studies provided control groups with an isocaloric placebo. Two studies provided the control groups with pills or capsules containing some nutrients, such as calcium or omega-3 [36, 49]. The intervention period ranged between 8 and 24 weeks: eight weeks in one study, 12 weeks in 13 studies, 14 weeks in one study, 18 weeks in one study, and 24 weeks in nine studies.

Risk of Bias

The risk of bias results for the 25 RCTs are demonstrated in Fig. 2. Regarding the randomization process, seven studies had a low risk of bias, 17 had some concerns, and one study had a high risk of bias because of a failure to conceal group allocation. Regarding deviation from the intended intervention, three had some concerns, and the others had a low risk of bias. As there were no studies in which missing values were judged to have an impact on the study results, all studies had a low risk of bias in the domain of missing outcome data. All studies had a low risk of bias in the domain of measurement of outcome, either because the outcome assessor was blinded or the outcome assessor’s awareness of the group assignments was judged to not affect the measurement of muscle mass, strength, or physical function. In the fifth domain, the selection of the reported results, 10 studies had a low risk of bias, while the other 15 studies had some concerns because of the absence of a prespecified trial protocol. Overall, five RCTs had a low risk of bias, 19 RCTs had some concerns, and one study had a high risk of bias.
Fig. 2

Risk of bias of the included studies

Risk of bias of the included studies

Effects of resistance training and nutritional interventions compared with those of resistance training only on muscle mass, muscle strength, and physical functional performance

The effect sizes and 95% confidence intervals (95% CIs) for individual studies and all studies are shown in Fig. 3. The results of the meta-analysis showed no significant effects on lean body mass (n = 12, MD 0.13, 95% CI − 0.75 to 1.02), appendicular skeletal muscle mass (n = 6, MD -0.01, 95% CI − 0.26 to 0.24), hand grip strength (n = 8, SMD 0.08, 95% CI − 0.11 to 0.27), knee extension strength (n = 15, SMD 0.09, 95% CI − 0.04 to 0.23), the chair stand test results (n = 7, MD -0.13, 95% CI − 0.43 to 0.17), or the timed up-and-go test results (n = 6, MD 0.02, 95% CI − 0.16 to 0.20). The I2 values for all outcomes except lean body mass were zero, indicating that heterogeneity might not be important for these outcomes and that lean body mass might represent moderate heterogeneity (I2 = 35%).
Fig. 3

Effects of resistance training and nutritional interventions compared with those of resistance training only on muscle mass, muscle strength, and physical functional performance

Effects of resistance training and nutritional interventions compared with those of resistance training only on muscle mass, muscle strength, and physical functional performance

Subgroup analysis according to type of nutritional interventions

The results of the subgroup analyses according to the type of nutritional interventions are shown in Table 2. The subgroup analyses for lean body mass showed significant differences between the types of nutritional interventions (Chi2 = 7.28, p = .03). Among the nutritional interventions, only those with creatine showed significant effects on lean body mass (n = 4, MD 2.61, 95% CI 0.51 to 4.72). Regarding the other subgroup analyses, there were no significant differences in appendicular skeletal muscle mass (χ2 = 0.62, p = .43), hand grip strength (χ2 = 0.12, p = .73), knee extension strength (χ2 = 4.89, p = .09), chair stand test results (χ2 = 1.05, p = .43), or timed up-and-go test results (χ2 = 1.02, p = .31). Although creatine showed significant effects on knee extension strength (n = 2, SMD 0.74, 95% CI 0.09 to 1.38), there were no significant subgroup differences.
Table 2

Subgroup analysis: effects by type of nutritional interventions on muscle mass, muscle Strength, and physical functional performance

SubgroupsLean body massAppendicular skeletal muscle mass
nMD95% CII2Subgroup differencesnMD95% CII2Subgroup differences
Creatine42.610.51 ~ 4.729%χ2 = 7.28 (p = .03)χ2 = 0.62 (p = .43)
Multi-nutrients20.94−1.94 ~ 3.8236%20.39−0.68 ~ 1.450%
Protein4−0.21− 0.57 ~ 0.140%2−0.20−1.23 ~ 0.8247%
SubgroupsHand grip strengthKnee extension strength
nSMD95% CII2Subgroup differencesnSMD95% CII2Subgroup differences
Creatineχ2 = 0.12 (p = .73)20.740.09 ~ 1.387%χ2 = 4.89 (p = .09)
Multi-nutrients2−0.04−0.48 ~ 0.4021%20.05−0.36 ~ 0.4612%
Protein30.05−0.21 ~ 0.310%6−0.02−0.20 ~ 0.170%
SubgroupsChair stand testTimed up and go test
nMD95% CII2Subgroup differencesnMD95% CII2Subgroup differences
Multi-nutrients20.15−0.41 ~ 0.720%χ2 = 1.05 (p = .31)20.26−0.31 ~ 0.8332%χ2 = 1.02 (p = .31)
Protein3−0.21−0.60 ~ 0.190%2−0.06−0.28 ~ 0.170%
Subgroup analysis: effects by type of nutritional interventions on muscle mass, muscle Strength, and physical functional performance

Moderator analysis with Meta-regression

As recommended [27], meta-regression was conducted when there were more than ten studies in a meta-analysis; therefore, meta-regression was performed on lean body mass (n = 12) and knee extension strength (n = 15). The mean age of the subjects and duration of interventions were included as explanatory variables in a univariate regression model. In the meta-regression, neither the mean age of the subjects (β = 0.01, SE = 0.04, t = 0.18, p = .858) nor the duration of interventions (β = − 0.001, SE = 0.02, t = − 0.04, p = .965) were associated with lean body mass. These moderators were not contributing variables to knee extension strength (β = − 0.03, SE = 0.03, t = − 0.90, p = .383; β = − 0.01, SE = 0.01, t = − 0.45, p = .660, respectively).

Sensitivity analysis

Sensitivity analysis was conducted to compare the effect sizes, 95% CIs, and I2 values by excluding two studies that provided some nutrients to control groups. There were no significant differences in lean body mass (n = 11, MD 0.20, 95% CI − 0.74 to 1.14), appendicular skeletal muscle mass (n = 5, MD 0.09, 95% CI − 0.23 to 0.40), hand grip strength (n = 7, MD 0.08, 95% CI − 0.12 to 0.28), knee extension strength (n = 14, MD 0.10, 95% CI − 0.04 to 0.24), chair stand test results (n = 7, MD -0.13, 95% CI − 0.43 to 0.17), or timed up-and-go test results (n = 4, MD 0.01, 95% CI − 0.18 to 0.20). The I2 values for all outcomes except for lean body mass were zero, indicating that heterogeneity might not be important for these outcomes and that lean body mass might have moderate heterogeneity (I2 = 40%). There were six outcomes to compare the quality of evidence for resistance training combined a nutritional intervention compared to resistance training alone for muscle function. The hand grip strength and chair stand test were of moderate certainty. The other outcomes were low. The GRADE summary of the findings is shown in Additional file 2.

Discussion

Nutrient-dense foods that ensure sufficient intake of energy, protein and micronutrients are important to prevent frailty and sarcopenia and promote physical activity. However, to date, the optimal type of nutritional intervention or supplementation for the prevention of frailty and sarcopenia is unclear. This study was conducted to compare the synergistic effect of nutritional interventions combined with resistance training with that of resistance training alone. This study can provide insight into resource optimization and strategies to prevent frailty and sarcopenia. This systematic review and meta-analysis showed that there were no additional effects of nutritional interventions when combined with resistance training on muscle mass, strength, or physical function. Of note, in two studies, the control conditions included some nutrients that have biological benefits [36, 49], which likely reduced the calculated effect size when the data for the control conditions were pooled. However, the findings of the sensitivity analysis showed little possibility of blunted effects. One of the possible reasons for this lack of significant results is that the analysis included studies of healthy older adults who might not have nutrient deficiencies with the usual diets [23]. Healthy diets provide a broad range of micronutrients and bioactive nonnutrients as well as macronutrients that might not be included in the experimental supplements in trials. In addition, since diets are patterned, isolating the effects of individual experimental supplements might not be possible without controlling for the usual diet. Thus, the effects of nutritional interventions might be blunted among older adults who habitually consume sufficient nutrients. However, in previous studies that provided vitamin D-deficient and mobility-limited older adults with a protein mixture containing 20 g protein, 800 IU vitamin D, 350 mg calcium, and other minerals once a day for 6 months with an exercise program, there were no differences in muscle function parameters such as leg strength, gait speed, and short physical performance battery between this group and the exercise-only control group except in muscle density [53, 54]. In another study that also provided sarcopenic older adults who had low protein intake with multinutrient supplements containing 21 g protein, 800 IU vitamin D and other nutrients once a day for 3 months with an exercise program, there were no differences between the two groups, although both groups exhibited improved muscle function [55]. It is necessary to additionally consider the dose of the nutrient and duration of intervention and monitor dietary energy intake. Despite the lack of evidence, greater benefits of resistance training along with nutritional supplementation are expected in older adults who already have poor muscle function or habitually have low nutrient intake. In the subgroup analysis of the types of nutrients, only creatine showed significant effects on lean body mass. Among the five studies included in this meta-analysis, four administered 5 g creatine daily combined with resistance training 3 times a week for 12 weeks [28, 34, 47]  or twice a week for 24 weeks [51], and one administered 5 g creatine four times a day for the first 5 days of the loading phase and 3 g creatine daily for the maintenance phase combined with resistance training 3 times a week for 7 weeks [31]. Recent systematic reviews similarly identified the additive effect of creatine during resistance training on body composition, muscle strength, and physical function [56, 57]. As skeletal muscle has no capacity for creatine biosynthesis, the consumption of creatine-containing food or supplementation of creatine increases creatine and phosphocreatine levels in skeletal muscle and elevates phosphate resynthesis (energy buffer) during high-energy demanded exercise, such as repetitive resistance training training [58, 59, 60]. Creatine helps to increase muscle mass and strength by indirectly increasing work capacity, and the combination of creatine supplementation and resistance training promotes muscle protein synthesis. Alternatively, creatine supplementation may enhance muscle protein synthesis stimulating signaling pathways (myogenic regulatory factors), which facilitate myosatellite cell proliferation and differentiation [61]. Controversy exists as to whether creatine stores and metabolism are affected by aging, but creatine supplements can account for dietary changes and reductions in physical activity with aging [57]. The effect sizes for variables other than lean body mass were not significant in this study. Additional meta-analyses including more experimental studies are needed to verify the effects of creatine on muscle mass and function in older adults. As proteins provide amino acids that are essential for muscle protein synthesis and act as anabolic stimuli, protein consumption increases muscle mass, and protein consumption following resistance training enhances net protein utilization, attenuating exercise-induced muscle protein breakdown [60, 62]. The combination of protein supplements and exercise was expected to have a synergistic effect on muscle function, but the findings of this study did not support this hypothesis. On the other hand, in a previous meta-analysis, protein supplements for sarcopenic older adults along with exercise showed a larger effect size than exercise alone and no intervention [24]. The previous meta-analysis was conducted in frail, sarcopenic, or mobility-limited older adults and included not only community-dwelling older adults but also institutionalized older adults. Individuals with existing nutritional deficiencies or poor muscle function might have been shown to respond better to accompanying nutritional supplements than to exercise alone. Additional studies are needed to determine whether the inconsistency in findings resulted from the characteristics of the subjects. Muscle protein synthesis through protein intake in older adults should be maximized with consideration of the frequency, distribution, and other nutritional components, such as creatine, vitamins, and fatty acids [22, 60]. It is recommended that older adults consume ≥0.4 g/kg per meal and 1.2–1.6 g/kg per day to induce muscle protein synthesis saturation to thus support muscle function [60]. Among the included studies, most studies provided 10.1 g–25 g protein once a day [39, 41, 42, 45]  or 20 g ~ 35 g protein 3 times a week on the days exercise was performed [30, 43, 50], which could not take into account frequency and distribution. A previous review showed that multi-ingredient protein supplements have the potential to increase the benefits of resistance training, but there were no differences in the effects on muscle mass and strength between multi-ingredient protein and single protein [63]. The impact of multiple nutrients is unclear, but there are complex interactions between food components inducing potential synergistic effects. Thus, nutritional interventions involving dietary modifications with various and balanced nutrients or whole food approaches rather than a single specific nutrient can be effective in improving muscle mass and function [64]. Among the 25 RCTs, three provided multinutrients that were arbitrarily defined as containing three or more nutrients. Of the three studies, only one used a whole-diet approach. The number of studies was too small to verify the effect of the whole-food or whole-diet approach. Nutritional effects may not manifest following dietary interventions of short durations. Although the meta-regression results did not show that the intervention period was associated with effect sizes, a 6-year longitudinal study showed a positive relationship between daily protein intake and muscle strength [65]; nutritional contributions can be expected to be observed in the long term. Thus, despite the nonsignificant results, nutritional interventions may still be beneficial for older adults who do not lack nutrients. With aging, muscle loss (breakdown) occurs more rapidly than muscle synthesis, so additional supplements may be required. In addition, older adults experience declines in food intake because of changes in appetite and a lack of hunger, which is referred to as ‘anorexia of aging’ [66]. As consumed food is metabolized to synthesize energy for organ function, poor nourishment leads to body fat and muscle being catabolized to provide energy. Not only a lack of specific nutrients but also the consumption of an insufficient amount of food contributes to weight loss and declines in muscle mass, strength and physical function, which can lead to physical frailty and sarcopenia. Thus, the consumption of an adequate amount of food containing nutrients essential for muscle function is important to maintain muscle mass, strength, and physical function [22, 58]. Considering that changes occur in various physiological functions as well as muscle function, interventions with a balanced diet are important in older people. As nutritional interventions have the advantages of low costs and high availability and accessibility, additional studies are necessary to determine whether they can be effective in preventing frailty and sarcopenia. This study has several limitations. First, this meta-analysis included only retrievable RCTs that were published in English, which may have contributed to language bias. Second, this study in healthy older adults might not have demonstrated significant effects on muscle mass, muscle strength, and physical function due to the ceiling effect. Additional systematic reviews and meta-analyses are needed to identify the additional effects of nutritional interventions when combined with resistance training among dynapenic, sarcopenic, or frail older adults. Third, the range of nutritional interventions included in this study were vast because each nutrient has a different mechanism that affects muscle synthesis, function, or prevention of muscle damage. Future studies need to be more focused on a specific nutritional intervention. Finally, as mentioned above, the amount, frequency, and distribution of nutrients administered are important to consider to fully assess the effects of nutritional interventions; however, these factors were not assessed in the meta-analysis. As the levels of variability in muscle mass and functional measurements are quite high in older adults, it is hard to obtain adequate statistical power to verify differences between groups in many studies on nutritional interventions. This meta-analysis showed that nutritional interventions have no additional effect on body composition, muscle strength, or physical function when combined with resistance training. Only creatine showed synergistic effects with resistance training on muscle mass. The enhanced effect of nutritional interventions for unhealthy older adults, such as frail, sarcopenic, or nutritionally deficient older adults, needs to be investigated in future studies. The long-term effects of nutrition on muscle function also need to be studied. In addition, additional studies should be conducted to identify the dietary parameters that maximize nutritional effects on muscle protein synthesis, including dose, frequency, distribution, and recipes that take into account interactions with other nutrients. Health-promoting interventions such as exercise and diet are important for at-risk older adults to prevent clinically evident disability. This systematic review and meta-analysis provides a comprehensive synthesis of the experimental results available to date for health practitioners and researchers to establish intervention strategies or public health policies. Additional file 1. PRISMA checklist. Additional file 2. Summary of findings and analysis of the quality of evidence.
  22 in total

1.  Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project.

Authors:  Leocadio Rodríguez-Mañas; Catherine Féart; Giovanni Mann; Jose Viña; Somnath Chatterji; Wojtek Chodzko-Zajko; Magali Gonzalez-Colaço Harmand; Howard Bergman; Laure Carcaillon; Caroline Nicholson; Angelo Scuteri; Alan Sinclair; Martha Pelaez; Tischa Van der Cammen; François Beland; Jerome Bickenbach; Paul Delamarche; Luigi Ferrucci; Linda P Fried; Luis Miguel Gutiérrez-Robledo; Kenneth Rockwood; Fernando Rodríguez Artalejo; Gaetano Serviddio; Enrique Vega
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-16       Impact factor: 6.053

Review 2.  Frailty in relation to the accumulation of deficits.

Authors:  Kenneth Rockwood; Arnold Mitnitski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-07       Impact factor: 6.053

3.  Polypharmacy and Incident Frailty in a Longitudinal Community-Based Cohort Study.

Authors:  Shahar Shmuel; Jennifer L Lund; Carolina Alvarez; Christine D Hsu; Priya Palta; Anna Kucharska-Newton; Joanne M Jordan; Amanda E Nelson; Yvonne M Golightly
Journal:  J Am Geriatr Soc       Date:  2019-10-24       Impact factor: 5.562

Review 4.  Frailty: implications for clinical practice and public health.

Authors:  Emiel O Hoogendijk; Jonathan Afilalo; Kristine E Ensrud; Paul Kowal; Graziano Onder; Linda P Fried
Journal:  Lancet       Date:  2019-10-12       Impact factor: 79.321

5.  The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses.

Authors:  A J Mayhew; K Amog; S Phillips; G Parise; P D McNicholas; R J de Souza; L Thabane; P Raina
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

Review 6.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

Review 7.  Frailty, Physical Frailty, Sarcopenia: A New Conceptual Model.

Authors:  Roberto Bernabei; Anna Maria Martone; Davide L Vetrano; Riccardo Calvani; Francesco Landi; Emanuele Marzetti
Journal:  Stud Health Technol Inform       Date:  2014

8.  Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function.

Authors:  Leandro Dos Santos; Edilson S Cyrino; Melissa Antunes; Diana A Santos; Luís B Sardinha
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-11-08       Impact factor: 12.910

9.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

10.  Prevalence and determinants of frailty in the absence of disability among older population: a cross sectional study from rural communities in Nepal.

Authors:  Uday Narayan Yadav; Man Kumar Tamang; Tarka Bahadur Thapa; Hassan Hosseinzadeh; Mark Fort Harris; Krishna Kumar Yadav
Journal:  BMC Geriatr       Date:  2019-10-22       Impact factor: 3.921

View more
  5 in total

Review 1.  Efficacy of Exercise on Muscle Function and Physical Performance in Older Adults with Sarcopenia: An Updated Systematic Review and Meta-Analysis.

Authors:  Haolin Wang; Wendy Y Huang; Yanan Zhao
Journal:  Int J Environ Res Public Health       Date:  2022-07-05       Impact factor: 4.614

2.  Correction: Does the combination of resistance training and a nutritional intervention have a synergic effect on muscle mass, strength, and physical function in older adults? A systematic review and meta-analysis.

Authors:  MoonKi Choi; Hayeon Kim; Juyeon Bae
Journal:  BMC Geriatr       Date:  2022-06-28       Impact factor: 4.070

3.  Lower Limb Muscle Strength and Muscle Mass Are Associated With Incident Symptomatic Knee Osteoarthritis: A Longitudinal Cohort Study.

Authors:  Nicola Veronese; Sinisa Stefanac; Ai Koyanagi; Nasser M Al-Daghri; Shaun Sabico; Cyrus Cooper; Renè Rizzoli; Jean-Yves Reginster; Mario Barbagallo; Ligia J Dominguez; Lee Smith; Stefania Maggi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-16       Impact factor: 5.555

Review 4.  Anabolic-Androgenic Steroids and Exercise Training: Breaking the Myths and Dealing With Better Outcome in Sarcopenia.

Authors:  Hugo Falqueto; Marcelo Rodrigues Dos Santos; Leandro H Manfredi
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

5.  Exercise-microbiota interactions in aging-related sarcopenia.

Authors:  Johannes Burtscher; Andrea Ticinesi; Gregoire P Millet; Martin Burtscher; Barbara Strasser
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-10       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.